BALBONI, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 1.901
EU - Europa 526
AS - Asia 402
OC - Oceania 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.835
Nazione #
US - Stati Uniti d'America 1.900
CN - Cina 227
UA - Ucraina 146
DE - Germania 122
TR - Turchia 98
GB - Regno Unito 71
IT - Italia 64
SG - Singapore 64
SE - Svezia 51
FI - Finlandia 33
PL - Polonia 11
FR - Francia 10
BE - Belgio 4
RU - Federazione Russa 4
CZ - Repubblica Ceca 3
NL - Olanda 3
AU - Australia 2
HK - Hong Kong 2
ID - Indonesia 2
IN - India 2
KR - Corea 2
VN - Vietnam 2
BN - Brunei Darussalam 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
IE - Irlanda 1
IQ - Iraq 1
IR - Iran 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 2.835
Città #
Houston 218
Fairfield 211
Woodbridge 196
Jacksonville 167
Chandler 151
Ann Arbor 131
Ashburn 126
Wilmington 80
Santa Clara 72
Cambridge 68
Beijing 64
Seattle 62
Nanjing 54
Singapore 42
Izmir 40
Milan 36
Princeton 34
San Diego 25
Bremen 23
Boardman 21
Shanghai 17
Dearborn 16
Nanchang 16
San Mateo 14
Jinan 11
Los Angeles 11
Shenyang 10
Warsaw 10
Ferrara 8
Zhengzhou 8
Indiana 6
Jiaxing 6
Tianjin 6
Addison 5
Kilburn 5
Mountain View 5
New York 5
Washington 5
Auburn Hills 4
Brussels 4
Changsha 4
Norwalk 4
Philadelphia 4
Redwood City 4
Bologna 3
Falls Church 3
Guangzhou 3
Kunming 3
Ningbo 3
Acton 2
Antea 2
Cagliari 2
Cosenza 2
Dong Ket 2
Fremont 2
Haikou 2
Hebei 2
Helsinki 2
Hong Kong 2
Jakarta 2
Redmond 2
San Francisco 2
Taizhou 2
Tappahannock 2
Verona 2
Albert Park 1
Amsterdam 1
Auckland 1
Augusta 1
Bandar Seri Begawan 1
Baotou 1
Canberra 1
Changchun 1
Chicago 1
Chongqing 1
Des Moines 1
Dublin 1
Düsseldorf 1
Edinburgh 1
Espoo 1
Frankfurt am Main 1
Hounslow 1
Jinhua 1
Lanzhou 1
Leawood 1
Leipzig 1
London 1
Munich 1
New Bedfont 1
North Charleston 1
Olomouc 1
Orange 1
Osasco 1
Oslo 1
Prague 1
Prescot 1
Taiyuan 1
Wandsworth 1
Wuxi 1
Yellow Springs 1
Totale 2.091
Nome #
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 157
A CYCLIC PEPTIDE T ANALOGUE WITH HIGH CHEMOTACTIC ACTIVITY 156
Design, Synthesis, DNA Binding, and Biological Evaluation of Water-Soluble Hybrid Molecules Containing Two Pyrazole Analogues of the Alkylating Cyclopropylpyrroloindole (CPI) Subunit of the Antitumor Agent CC-1065 and Polypyrrole Minor Groove Binders. 148
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 142
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 136
Critical role for prokineticin 2 in CNS autoimmunity 115
Design of d-opioid peptide antagonists for emerging drug applications 114
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 113
Opioid diketopiperazines: Synthesis and activity of a prototypic class of opioid antagonists 110
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 104
Assessment of substitution in the second pharmacophore of Dmt-Tic analogues 101
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 98
Characterization of N,N(Me)(2)-Dmt-Tic-OH, a delta selective opioid dipeptide antagonist 90
null 90
Tritiation of delta opioid-receptor selective antagonist dipeptide ligands with extraordinary affinity containing 2 ', 6 ' dimethyltyrosine 89
Evaluation of the Dmt-Tic pharmacophore: Conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties 83
Design and solution structure of a partially rigid opioid antagonist lacking the basic center - Models of antagonism 81
Conformational analysis of potent and very selective delta opioid dipeptide antagonists 80
Design of μ selective opioid dipeptide antagonists 74
Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test amd regulate BDNF mRNA expression in rats. 74
Opioid diketopiperazines: Refinement of the delta opioid antagonist pharmacophore 72
Further Studies on the Dmt-Tic Pharmacophore: Hydrophobic Substituents at the C-Terminus Endow delta Antagonists To Manifest mu Agonism or mu Antagonism 70
Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent delta-opioid antagonist 70
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist, correlation between desensitization and tolerance. 68
Inverse agonism by Dmt-Tic analogues and H5 378, a naltrindole analogue 66
Delta-, but not mu-, opioid receptor stabilize K+ homeostasis by reducing Ca2+ influx in the cortex during acute hypoxia. 66
DMT-TIC-OH, a highly selective and potent delta-opioid dipeptide receptor antagonist after systemic administration in the mouse 64
Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary δ opioid antagonist activity 64
Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore 58
null 46
Synthesis, metabolic stability and chemotactic activity of peptide T and its analogues 29
Synthesis and opioid activity of N,N-dimethyl-Dmt-Tic-NH-CH(R)-R ' analogues: Acquisition of potent delta antagonism 18
Opioid pseudopeptides containing heteroaromatic or heteroaliphatic nuclei 14
Totale 2.860
Categoria #
all - tutte 13.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020396 0 0 0 0 36 85 57 59 34 75 40 10
2020/2021386 33 32 8 60 7 39 18 41 11 52 61 24
2021/2022324 8 34 35 21 28 9 14 16 16 21 22 100
2022/2023372 33 8 21 43 73 45 32 41 37 3 16 20
2023/2024173 12 33 13 6 11 37 13 12 1 5 1 29
2024/2025175 17 11 50 19 78 0 0 0 0 0 0 0
Totale 2.860